These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 11061993)

  • 21. The effect of cilostazol, a cyclic nucleotide phosphodiesterase III inhibitor, on heparin-binding EGF-like growth factor expression in macrophages and vascular smooth muscle cells.
    Kayanoki Y; Che W; Kawata S; Matsuzawa Y; Higashiyama S; Taniguchi N
    Biochem Biophys Res Commun; 1997 Sep; 238(2):478-81. PubMed ID: 9299535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disparate effects of thyroid hormone on actions of epidermal growth factor and transforming growth factor-alpha are mediated by 3',5'-cyclic adenosine 5'-monophosphate-dependent protein kinase II.
    Shih A; Zhang S; Cao HJ; Tang HY; Davis FB; Davis PJ; Lin HY
    Endocrinology; 2004 Apr; 145(4):1708-17. PubMed ID: 14691008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An assessment of the role of the inhibitory gamma subunit of the retinal cyclic GMP phosphodiesterase and its effect on the p42/p44 mitogen-activated protein kinase pathway in animal and cellular models of pulmonary hypertension.
    Murray F; MacLean MR; Pyne NJ
    Br J Pharmacol; 2003 Apr; 138(7):1313-9. PubMed ID: 12711632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of cyclooxygenase 2, p38 and p42/44 MAPK in the secretion of prostacyclin induced by epidermal growth factor, endothelin-1 and angiotensin II in rat ventricular cardiomyocytes.
    Rebsamen MC; Capoccia R; Vallotton MB; Lang U
    J Mol Cell Cardiol; 2003 Jan; 35(1):81-9. PubMed ID: 12623302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of mitogen-activated protein kinase by cholinergic agonists and EGF in human compared with rat cultured conjunctival goblet cells.
    Horikawa Y; Shatos MA; Hodges RR; Zoukhri D; Rios JD; Chang EL; Bernardino CR; Rubin PA; Dartt DA
    Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2535-44. PubMed ID: 12766054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of chronic ethanol treatment on the angiotensin II-mediated p42/p44 mitogen-activated protein kinase and phosphorylase a activation in rat hepatocytes.
    Weng YI; Shukla SD
    Alcohol; 2003 Feb; 29(2):83-90. PubMed ID: 12782249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dual blockade of mitogen-activated protein kinases ERK-1 (p42) and ERK-2 (p44) and cyclic AMP response element binding protein (CREB) by neomycin inhibits glioma cell proliferation.
    Cuevas P; Diaz-González D; Carceller F; Dujovny M
    Neurol Res; 2003 Jan; 25(1):13-6. PubMed ID: 12564119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of alpha1D-adrenergic receptors on shedding of biologically active EGF in freshly isolated lacrimal gland epithelial cells.
    Chen L; Hodges RR; Funaki C; Zoukhri D; Gaivin RJ; Perez DM; Dartt DA
    Am J Physiol Cell Physiol; 2006 Nov; 291(5):C946-56. PubMed ID: 16760267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of PI3K and p42/p44 MAPK on overexpression of vascular endothelial growth factor in hepatocellular carcinoma.
    Huang GW; Yang LY; Lu WQ
    World J Gastroenterol; 2004 Mar; 10(6):809-12. PubMed ID: 15040022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Nuclear-cytoplasmic distribution of MAP-kinase isoforms p42 and p44 after treatment with epidermal growth factors (EGF) of cells with different functional state of EGF receptor].
    Arnautov AM; Nikol'skiĭ NN
    Tsitologiia; 1998; 40(7):633-8. PubMed ID: 9793176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidermal growth factor regulates astrocyte expression of the interleukin-4 receptor via a MAPK-independent pathway.
    Barna BP; Mattera R; Jacobs BS; Drazba J; Estes ME; Prayson RA; Barnett GH
    Cell Immunol; 2001 Feb; 208(1):18-24. PubMed ID: 11277615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ethanol alters angiotensin II stimulated mitogen activated protein kinase in hepatocytes: agonist selectivity and ethanol metabolic independence.
    Weng Y; Shukla SD
    Eur J Pharmacol; 2000 Jun; 398(3):323-31. PubMed ID: 10862821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phosphotidylethanol mimics ethanol modulation of p42/44 mitogen-activated protein kinase signalling in hepatocytes.
    Aroor AR; Custer GW; Weng YI; Lee YJ; Shukla SD
    Alcohol Alcohol; 2002; 37(6):534-9. PubMed ID: 12414543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.
    Takada Y; Ichikawa H; Pataer A; Swisher S; Aggarwal BB
    Oncogene; 2007 Feb; 26(8):1201-12. PubMed ID: 16924232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TLR5-mediated activation of p38 MAPK regulates epithelial IL-8 expression via posttranscriptional mechanism.
    Yu Y; Zeng H; Lyons S; Carlson A; Merlin D; Neish AS; Gewirtz AT
    Am J Physiol Gastrointest Liver Physiol; 2003 Aug; 285(2):G282-90. PubMed ID: 12702497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of heparin-binding EGF-like growth factor and activation of EGF receptor in imatinib mesylate-treated squamous carcinoma cells.
    Johnson FM; Saigal B; Donato NJ
    J Cell Physiol; 2005 Nov; 205(2):218-27. PubMed ID: 15887238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclic AMP inhibits agonist-induced heparin-binding EGF gene expression independently of effects on p42/p44 MAPK activation.
    Ellis PD; Hadfield KM; Pascall JC; Brown KD
    Biochem Biophys Res Commun; 2000 Nov; 277(3):558-61. PubMed ID: 11061993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitory effect of antisense oligodeoxynucleotide to p44/p42 MAPK on angiotensin II-induced hypertrophic response in cultured neonatal rat cardiac myocyte.
    Zhang SQ; Ding B; Guo ZG; Li YX
    Acta Pharmacol Sin; 2004 Jan; 25(1):41-6. PubMed ID: 14704121
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.